STOCK TITAN

Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

SenesTech (NASDAQ: SNES) announces that the City of Baltimore has integrated Evolve™, their rodent birth control product, into the city's pest management programs. Baltimore, recently ranked among America's 'rattiest cities', has placed a substantial initial order for deployment this quarter.

The initiative aims to address rodent overpopulation through a non-lethal approach that targets reproduction in both male and female rodents. Guy Bell, Chief of the Property Management Division at Baltimore City Department of Public Works, supports the strategy of preventing rat breeding. Joel Fruendt, SenesTech's CEO, emphasizes the product's role in addressing urban rodent challenges.

Evolve, designated as 'minimum risk' by the EPA, offers a sustainable alternative to traditional poisons and traps. The deployment will initially focus on high-impact areas to evaluate effectiveness in reducing rodent populations while ensuring environmental and public health safety.

SenesTech (NASDAQ: SNES) annuncia che la città di Baltimora ha integrato Evolve™, il loro prodotto per il controllo della nascita dei roditori, nei programmi di gestione dei parassiti della città. Baltimora, recentemente classificata tra le 'città più infestata dai ratti' d'America, ha effettuato un ordine iniziale sostanziale per il dispiegamento in questo trimestre.

L'iniziativa mira ad affrontare il problema della sovrappopolazione dei roditori attraverso un approccio non letale che colpisce la riproduzione sia dei maschi che delle femmine. Guy Bell, capo della Divisione Gestione Proprietà del Dipartimento dei Lavori Pubblici della città di Baltimora, sostiene la strategia di prevenire la riproduzione dei ratti. Joel Fruendt, CEO di SenesTech, sottolinea il ruolo del prodotto nell'affrontare le sfide dei roditori urbani.

Evolve, designato come 'rischio minimo' dall'EPA, offre un'alternativa sostenibile ai tradizionali veleni e trappole. Il dispiegamento si concentrerà inizialmente sulle aree ad alto impatto per valutare l'efficacia nella riduzione delle popolazioni di roditori, garantendo al contempo la sicurezza ambientale e per la salute pubblica.

SenesTech (NASDAQ: SNES) anuncia que la ciudad de Baltimore ha integrado Evolve™, su producto de control de natalidad para roedores, en los programas de gestión de plagas de la ciudad. Baltimore, recientemente clasificada entre las 'ciudades más infestadas de ratas' de Estados Unidos, ha realizado un pedido inicial sustancial para su implementación en este trimestre.

La iniciativa tiene como objetivo abordar la sobrepoblación de roedores a través de un enfoque no letal que ataca la reproducción tanto de machos como de hembras. Guy Bell, Jefe de la División de Gestión de Propiedades del Departamento de Obras Públicas de Baltimore, apoya la estrategia de prevenir la reproducción de ratas. Joel Fruendt, CEO de SenesTech, enfatiza el papel del producto en la solución de los desafíos urbanos relacionados con los roedores.

Evolve, designado como 'riesgo mínimo' por la EPA, ofrece una alternativa sostenible a los venenos y trampas tradicionales. La implementación se centrará inicialmente en áreas de alto impacto para evaluar la efectividad en la reducción de las poblaciones de roedores, asegurando al mismo tiempo la seguridad ambiental y de la salud pública.

SenesTech (NASDAQ: SNES)는 볼티모어 시가 도시의 해충 관리 프로그램에 Evolve™, 그들의 설치류 출산 조절 제품을 통합했다고 발표했습니다. 최근 '미국 내 가장 쥐가 많은 도시'로 평가된 볼티모어는 이번 분기에 배치를 위한 상당한 초기 주문을 하였습니다.

이 이니셔티브는 수컷과 암컷 설치류 모두의 번식을 목표로 하는 비치명적 접근 방식을 통해 설치류 과잉 개체 수 문제를 해결하는 데 목적을 두고 있습니다. 볼티모어 공공사업부의 재산 관리 부서장인 가이 벨(Guy Bell)은 쥐 번식 방지 전략을 지지합니다. SenesTech의 CEO인 조엘 프룬트(Joel Fruendt)는 제품이 도시 내 설치류 문제를 해결하는 데 기여하는 역할을 강조합니다.

Evolve는 EPA에 의해 '최소 위험'으로 지정되었으며, 전통적인 독성과 덫에 대한 지속 가능한 대안을 제공합니다. 배치는 처음에 영향력이 큰 지역에 집중되어 설치류 개체 수를 줄이는 효과를 평가하고, 동시에 환경 및 공공 보건 안전을 보장할 예정입니다.

SenesTech (NASDAQ: SNES) annonce que la ville de Baltimore a intégré Evolve™, leur produit de contrôle des naissances pour les rongeurs, dans les programmes de gestion des nuisibles de la ville. Baltimore, récemment classée parmi les 'villes les plus rongeurs' d'Amérique, a passé une commande initiale substantielle pour une mise en œuvre ce trimestre.

L'initiative vise à lutter contre la surpopulation de rongeurs par une approche non létale qui cible la reproduction tant chez les mâles que chez les femelles. Guy Bell, responsable de la Division de Gestion des Propriétés au Département des Travaux Publics de Baltimore, soutient la stratégie de prévention de la reproduction des rats. Joel Fruendt, PDG de SenesTech, souligne le rôle du produit dans la résolution des défis urbains liés aux rongeurs.

Evolve, désigné comme 'risque minimum' par l'EPA, offre une alternative durable aux poisons et pièges traditionnels. La mise en œuvre se concentrera au début sur les zones à fort impact afin d'évaluer l'efficacité de la réduction des populations de rongeurs tout en garantissant la sécurité environnementale et de la santé publique.

SenesTech (NASDAQ: SNES) gibt bekannt, dass die Stadt Baltimore Evolve™, ihr Produkt zur Geburtenkontrolle bei Nagetieren, in die Programme zur Schädlingsbekämpfung der Stadt integriert hat. Baltimore, kürzlich als eine der 'rattigsten Städte' Amerikas eingestuft, hat eine beträchtliche Erstbestellung für die Bereitstellung in diesem Quartal aufgegeben.

Die Initiative zielt darauf ab, das Problem der Nagetierüberpopulation durch einen nicht-tödlichen Ansatz anzugehen, der die Fortpflanzung bei sowohl männlichen als auch weiblichen Nagetieren gezielt anspricht. Guy Bell, Leiter der Abteilung Immobilienverwaltung im Amt für öffentliche Arbeiten der Stadt Baltimore, unterstützt die Strategie zur Verhinderung der Rattenzucht. Joel Fruendt, CEO von SenesTech, betont die Rolle des Produkts bei der Bewältigung der urbanen Nagetierproblematik.

Evolve, das von der EPA als 'minimal risk' eingestuft wurde, bietet eine nachhaltige Alternative zu traditionellen Giften und Fallen. Der Einsatz wird zunächst auf stark betroffene Bereiche fokussiert, um die Wirksamkeit bei der Reduktion der Nagetierpopulationen zu bewerten, während gleichzeitig die Umwelt- und öffentliche Gesundheitssicherheit gewährleistet bleibt.

Positive
  • Secured substantial initial order from major US city (Baltimore)
  • Product deployment scheduled for immediate quarter
  • EPA designated product as 'minimum risk'
  • Integration into established city pest management program
Negative
  • None.

Insights

The Baltimore contract represents a notable commercial milestone for SenesTech, marking the first major city adoption of Evolve™ since its launch. With Baltimore ranking among America's "rattiest cities," this deployment serves as a high-profile test case that could influence other metropolitan areas' pest control strategies. The initial order size and planned Q1 2025 deployment provide near-term revenue visibility for SNES, though specific financial terms weren't disclosed.

The urban pest control market presents substantial opportunities - the global rodenticide market is projected to reach $7.1 billion by 2026. If Evolve demonstrates effectiveness in Baltimore, it could accelerate adoption by other major cities struggling with rodent control. However, with a market cap of just $2.89 million, SNES remains a micro-cap stock with significant execution risks despite the positive momentum from this contract win.

For context, traditional rodenticides face increasing regulatory scrutiny due to environmental and safety concerns. Evolve's EPA "minimum risk" designation provides a competitive advantage in the evolving regulatory landscape, particularly for municipal customers with strict environmental guidelines.

The adoption of Evolve™ by Baltimore represents a paradigm shift in urban pest management, moving from reactive lethal methods to proactive population control. The scientific approach of targeting reproduction rather than using acute toxicants addresses a critical gap in sustainable pest control solutions. Traditional rodenticides often lead to secondary poisoning of predator species and can contaminate water systems, while Evolve's fertility control mechanism minimizes these environmental risks.

The EPA's "minimum risk" classification is particularly noteworthy as it indicates the product meets stringent safety standards for urban deployment. This classification facilitates faster adoption by municipalities as it reduces regulatory hurdles and environmental impact assessment requirements. The timing aligns with growing public demand for humane pest control solutions and increasing regulatory pressure on traditional rodenticides.

Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats

PHOENIX, Jan. 21, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step in Baltimore's efforts to address its significant rodent population, a challenge highlighted by a recent ranking of Baltimore as one of America's "rattiest cities." The city has placed a substantial initial order for Evolve and plans to deploy the product this quarter as part of its integrated pest management (IPM) strategy.

Baltimore's Forward-Thinking Approach
Baltimore is taking proactive measures to reduce its rodent population in a sustainable, humane, and effective manner. Evolve targets the root cause of rodent infestations—reproduction. By restricting reproduction in both male and female rodents, Evolve offers a non-lethal solution that reduces the rodent population over time, complementing traditional pest management tools.

In a recent interview, Guy Bell, Chief of the Property Management Division at the Baltimore City Department of Public Works, emphasized the importance of this initiative: "If we can stop the rats from breeding, that will help us out." 

"Rodents pose a significant public health and infrastructure challenge, especially in urban centers like Baltimore," said Joel Fruendt, President and CEO of SenesTech. "We're excited to partner with Baltimore to implement Evolve in its pest control strategy. By addressing the reproductive rate, Evolve provides a lasting and humane solution to a persistent problem."

A Humane and Sustainable Solution
Unlike poisons or traps, which are often reactive and fail to address the root cause of rodent overpopulation, Evolve Rodent Birth Control works by reducing fertility rates. When incorporated into pest management programs, Evolve has been shown to significantly decrease rodent populations over time. Its EPA-designated "minimum risk" classification ensures that it is safe for people, pets, wildlife, and the environment.

The Baltimore Deployment
The City of Baltimore's decision to implement Evolve underscores its commitment to innovative and sustainable solutions for pest management. The initial deployment will focus on high-impact areas, with the goal of evaluating its effectiveness in reducing rodent populations while minimizing environmental and public health risks.

About SenesTech
SenesTech is committed to creating healthier environments by humanely managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve™, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective, and sustainable.

For more information, visit https://senestech.com.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that Baltimore's integration of Evolve into its pest management programs marks a pivotal step in Baltimore's efforts to address its significant rodent population; plans to deploy Evolve this quarter as part of Balitmore's integrated pest management strategy; our belief that Evolve provides a lasting and humane solution to a persistent problem; and Baltimore's initial deployment focus on high-impact areas with the goal of evaluating its effectiveness in reducing rodent populations while minimizing environmental and public health risks.

Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to maintain compliance with Nasdaq's continued listing requirements; regulatory approval and regulation of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

Media Contact:

Rochelle Paulet
Director of Marketing
SenesTech, Inc.
(928) 779-4143 x814
rochelle.paulet@senestech.com

Investor Relations Contact:

Robert Blum
Lytham Partners, LLC
(602) 889-9700
senestech@lythampartners.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/baltimore-adopts-evolve-rodent-birth-control-for-integrated-pest-management-targeting-rodent-overpopulation-302354652.html

SOURCE SenesTech, Inc.

FAQ

What is the value of Baltimore's initial order for SenesTech's (SNES) Evolve product?

The press release describes it as 'substantial' but does not disclose the specific value of the initial order.

When will Baltimore deploy SenesTech's (SNES) Evolve rodent birth control?

The deployment is scheduled for the current quarter of 2025.

How does SenesTech's (SNES) Evolve product work to control rodent populations?

Evolve works by reducing fertility rates in both male and female rodents, offering a non-lethal solution that decreases rodent populations over time.

What is the EPA classification for SenesTech's (SNES) Evolve product?

The EPA has designated Evolve as a 'minimum risk' product, indicating it is safe for people, pets, wildlife, and the environment.

Where will Baltimore initially deploy SenesTech's (SNES) Evolve product?

The initial deployment will focus on high-impact areas within Baltimore city.

SenesTech, Inc.

NASDAQ:SNES

SNES Rankings

SNES Latest News

SNES Stock Data

3.02M
1.03M
0.02%
1.89%
4.64%
Specialty Chemicals
Agricultural Chemicals
Link
United States of America
PHOENIX